Related Experiment Video
Updated: May 2, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 19, 2013
Complications and total care of a child with acute leukemia
Insights
Children with acute leukemia face complications like marrow failure, organ dysfunction, and metabolic issues, especially after treatment. Understanding these potential adverse effects is crucial for effective management and minimizing harm.
Area of Science:
- Pediatric Oncology
- Hematology
Background:
- Acute leukemia in children presents diverse complications.
- Manifestations range from marrow failure to organ dysfunction due to leukemic infiltrates.
Purpose of the Study:
- To outline the spectrum of complications in pediatric acute leukemia.
- To emphasize the importance of physician knowledge in managing these adverse events.
Main Methods:
- Review of known complications associated with acute leukemia in children.
- Discussion of disease stage and therapeutic regimen influences.
Main Results:
- Complications include marrow failure, leukocytosis with organ dysfunction, metabolic disturbances (hyperuricemia, hyperphosphatemia-hypocalcemia), myelosuppression, immunosuppression leading to infections, and varied chemotherapeutic toxicities.
- Central nervous system therapy can cause symptoms from meningismus to paraplegia.
Conclusions:
- Physician awareness of the etiology, clinical/laboratory manifestations, and treatment of complications is vital.
- Proactive management is necessary to prevent and treat adverse events in pediatric acute leukemia patients.
Abstract:
The complications which occur in a child with acute leukemia depend on the stage of the disease and the therapeutic regiman. Most children will present with some manifestation of marrow failure. An occasional child will have marked leukocytosis and disturbance of organ function due to massive leukemic infiltrates. Metabolic disturbances such as hyperuricemia and hyperphosphatemia-hypocalcemia may develop, expecially after therapy is initiated. The myelosuppression and immunosuppression due to drug toxicity may result in opportunistic infections. Other toxicities which can occur with a chemotherapeutic regimen are numerois and varied, and the physician must be cognizant of them in order to minimize damage. Therapy to the central nervous system, either for subclinical or clinical disease, has been associated with a variety of symptoms ranging from meningismus to paraplegia and death. To prevent the development of these complications, and to manage them effectively if they occur, the physician must be knowlegeable about their etiology, clinical and laboratory manifestations, and treatment.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Kidney Transplant III: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease IV: Nursing Management